Home GeneSys

GeneSys

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Roles and Responsibilities of an Area Sales Manager

March 28, 2020

Retail Survey | Retail Counter Prescription Audit (RCPA) | Importance &...

October 25, 2022

What is the Induction of a Medical Representative? | Free Webinar...

June 10, 2023

HOT NEWS

News & Articles

Heat Stroke | Symptoms | Causes | Complications | Prevention |...

Interview Questions

Interview Questions – Area Manager in Pharmaceutical Companies

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

News & Articles